Skip to main content

JENNISON ASSOCIATES LLC

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 53417 NEW YORK, NY

Position in XENE

as of Mar 31, 2026 · filed May 6, 2026
Position Value
$76,689,034
+$18,779,129 QoQ
Shares Held
1,318,814
+2.1% QoQ
Ownership
1.36%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 72.31649042245533.ToString("F0")% Shared 0.ToString("F0")% None 27.683509577544672.ToString("F0")%

Common Shares in XENE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JENNISON ASSOCIATES LLC holds $3,287,290,858 across 47 Biotechnology names. XENE ranks #14 (2.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XENE

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $76,689,034 1,318,814
2025-12-31 $57,909,905 1,292,055
2025-09-30 $45,579,685 1,135,235
2025-06-30 $21,796,787 696,383
2025-03-31 $26,058,050 776,693
2024-12-31 $31,420,877 801,553
2024-09-30 $22,703,143 576,661
2024-06-30 $22,234,905 570,272
2024-03-31 $24,278,133 563,952
2023-12-31 $26,088,199 566,396
2023-09-30 $7,304,193 213,823
2023-06-30 $7,253,053 188,391